These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21749867

  • 1. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
    Pérès EA, Valable S, Guillamo JS, Marteau L, Bernaudin JF, Roussel S, Lechapt-Zalcman E, Bernaudin M, Petit E.
    Exp Cell Res; 2011 Oct 01; 317(16):2321-32. PubMed ID: 21749867
    [Abstract] [Full Text] [Related]

  • 2. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
    Yin D, Kawabata H, Tcherniamtchouk O, Huynh T, Black KL, Koeffler HP.
    Int J Oncol; 2007 Nov 01; 31(5):1193-8. PubMed ID: 17912447
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M, Lappin TR.
    Mol Cancer Res; 2010 Apr 01; 8(4):615-26. PubMed ID: 20353997
    [Abstract] [Full Text] [Related]

  • 4. Survival and invasiveness of astrocytomas promoted by erythropoietin.
    Mohyeldin A, Dalgard CL, Lu H, Mcfate T, Tait AS, Patel VC, Wong K, Rushing E, Roy S, Acs G, Verma A.
    J Neurosurg; 2007 Feb 01; 106(2):338-50. PubMed ID: 17410721
    [Abstract] [Full Text] [Related]

  • 5. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury.
    Kato S, Aoyama M, Kakita H, Hida H, Kato I, Ito T, Goto T, Hussein MH, Sawamoto K, Togari H, Asai K.
    J Neurosci Res; 2011 Oct 01; 89(10):1566-74. PubMed ID: 21833990
    [Abstract] [Full Text] [Related]

  • 6. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
    Pérès EA, Gérault AN, Valable S, Roussel S, Toutain J, Divoux D, Guillamo JS, Sanson M, Bernaudin M, Petit E.
    Oncotarget; 2015 Feb 10; 6(4):2101-19. PubMed ID: 25544764
    [Abstract] [Full Text] [Related]

  • 7. Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice.
    Kang BM, Shin SH, Kwack MH, Shin H, Oh JW, Kim J, Moon C, Moon C, Kim JC, Kim MK, Sung YK.
    J Dermatol Sci; 2010 Aug 10; 59(2):86-90. PubMed ID: 20554434
    [Abstract] [Full Text] [Related]

  • 8. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
    Li X, Gonias SL, Campana WM.
    Glia; 2005 Sep 10; 51(4):254-65. PubMed ID: 15812815
    [Abstract] [Full Text] [Related]

  • 9. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F, Aguennouz M, La Torre D, Sfacteria A, Grasso G.
    World Neurosurg; 2019 Nov 10; 131():346-355. PubMed ID: 31658577
    [Abstract] [Full Text] [Related]

  • 10. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA, Percy MJ, Boland MP, Maxwell AP, Lappin TR.
    Neurodegener Dis; 2006 Nov 10; 3(1-2):94-100. PubMed ID: 16909043
    [Abstract] [Full Text] [Related]

  • 11. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O, Fusil F, Henri A, Villette JM, Leboulch P, Beuzard Y, Payen E.
    Exp Hematol; 2008 Apr 10; 36(4):412-23. PubMed ID: 18295963
    [Abstract] [Full Text] [Related]

  • 12. Lack of expression and function of erythropoietin receptors in the kidney.
    Elliott S, Busse L, Swift S, McCaffery I, Rossi J, Kassner P, Begley CG.
    Nephrol Dial Transplant; 2012 Jul 10; 27(7):2733-45. PubMed ID: 22167585
    [Abstract] [Full Text] [Related]

  • 13. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, Brann DW.
    J Neurosci Res; 2007 Apr 10; 85(5):1033-45. PubMed ID: 17335076
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
    Chen ZY, Wang L, Asavaritkrai P, Noguchi CT.
    J Neurosci Res; 2010 Nov 01; 88(14):3180-8. PubMed ID: 20806411
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M, Ilner T, Rodt T, Samii M, Brandis A, Lenarz T, Stöver T.
    Otol Neurotol; 2007 Jun 01; 28(4):559-65. PubMed ID: 17429338
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
    Bose C, Udupa KB.
    Am J Physiol Cell Physiol; 2008 Aug 01; 295(2):C394-405. PubMed ID: 18550701
    [Abstract] [Full Text] [Related]

  • 17. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M, Gross AW, Lodish HF.
    Cell Signal; 2007 Mar 01; 19(3):634-45. PubMed ID: 17045782
    [Abstract] [Full Text] [Related]

  • 18. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C, Aguilar C, Lopez-Marure R, Jiménez-Sánchez A, Rocha-Zavaleta L.
    Mol Med Rep; 2014 May 01; 9(5):1895-902. PubMed ID: 24626629
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ.
    Prostate; 2006 Feb 01; 66(2):135-45. PubMed ID: 16161153
    [Abstract] [Full Text] [Related]

  • 20. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D, Mundigl O, Wessner A, Gremse F, Bachmann J, Rodriguez A, Klingmüller U, Jarsch M, Kiessling F, Lederle W.
    J Nucl Med; 2012 Feb 01; 53(2):304-11. PubMed ID: 22228796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.